The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity
Open accessAbstract
cytolytic T cells. In contrast, the temporally distinct elaboration of IFN-γ in progressively growing tumors also promotes a state of adaptive resistance caused by the up-regulation of inhibitory molecules, such as programmed-death ligand 1 (PD-L1) on tumor cell targets, and additional host cells within the tumor microenvironment. This review focuses on the diverse positive and negative roles of IFN-γ in immune cell activation and differentiation leading to protective immune responses, as well as the paradoxical effects of IFN-γ within the tumor microenvironment that determine the ultimate fate of that tumor in a cancer-bearing individual.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 4×
“THE IFN-γ SIGNALING PATHWAY The signaling pathways activated downstream from the IFNGR rely almost entirely on two families of proteins: protein tyrosine kinases that are members of the JAK family and one member of the STAT family of transcription factors (Darnell et al. 1994).”
BackgroundInfluentialPrimary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Self-citationCloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Taube, J. M., Anders, R. A., Young, G. D., Xu, H., Sharma, R., McMiller, T. L., Chen, S., Klein, A. P., Pardoll, D. M., Topalian, S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003689 · Cited by 2,157
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Self-citationA family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
(2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,655
Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10501 · Cited by 1,580
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Self-citationAdaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Self-citationA new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
Self-citationCancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Matsushita, H., Vesely, M. D., Koboldt, D. C., Rickert, C. G., Uppaluri, R., Magrini, V. J., Arthur, C. D., White, J. M., Chen, Y.-S., Shea, L. K., et al. (2012) · Nature · doi:10.1038/nature10755 · Cited by 1,288
Self-citationAltered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondii
Suzuki, Y., Orellana, M. A., Schreiber, R. D., & Remington, J. S. (1988) · Science · doi:10.1126/science.3128869 · Cited by 1,173
Self-citationStructure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells
Afkarian, M., Sedy, J. R., Yang, J., Jacobson, N. G., Cereb, N., Yang, S. Y., Murphy, T. L., & Murphy, K. M. (2002) · Nature Immunology · doi:10.1038/ni794 · Cited by 1,037
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
Self-citationMECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Self-citationAssembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261570598 · Cited by 783 · cited 1×
“The T-bet transcription factor is a master regulator of the Th1 phenotype and transcriptionally up-regulates the expression of both the IL-12 receptor and IFN-γ (Lighvani et al. 2001; Afkarian et al. 2002; Agnello et al. 2003).”
BackgroundTripp, C. S., Wolf, S. F., & Unanue, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3725 · Cited by 776
Inhibition of Stat1-mediated gene activation by PIAS1
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., & Shuai, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10626 · Cited by 765
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
Liew, F. Y., Millott, S., Parkinson, C., Palmer, R. M. J., & Moncada, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4794 · Cited by 736
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Self-citationInterferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627
Stetson, D. B., Mohrs, M., Reinhardt, R. L., Baron, J. L., Wang, Z.-E., Gapin, L., Kronenberg, M., & Locksley, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030630 · Cited by 617
ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
Gao, J., Ward, J. F., Pettaway, C. A., Shi, L. Z., Subudhi, S. K., Vence, L. M., Zhao, H., Chen, J., Chen, H., Efstathiou, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4308 · Cited by 594
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Harrington, L. E., Mangan, P. R., & Weaver, C. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.017 · Cited by 590
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
Ramana, C. V., Gil, M. P., Schreiber, R. D., & Stark, G. R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02118-4 · Cited by 555
Self-citationBuchmeier, N. A., & Schreiber, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7404 · Cited by 542
Self-citationExpression of tumour-specific antigens underlies cancer immunoediting
DuPage, M., Mazumdar, C., Schmidt, L. M., Cheung, A. F., & Jacks, T. (2012) · Nature · doi:10.1038/nature10803 · Cited by 529
Liew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522 · cited 1×
“Nitric oxide produced by macrophages downstream from IFN-γ signaling, in combination withNF-κB signaling, directly confers resistance against the growth of intracellular pathogens (Liew et al. 1990a,b).”
BackgroundActivation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., & Fu, X.-Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5328 · Cited by 521
SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality
Marine, J.-C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A., & Ihle, J. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80048-3 · Cited by 516
Structure of the human immune interferon gene
Gray, P. W., & Goeddel, D. V. (1982) · Nature · doi:10.1038/298859a0 · Cited by 508
Signal transduction by the TCR for antigen
Kane, L. P., Lin, J., & Weiss, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00083-2 · Cited by 498
Two contact regions between Stat1 and CBP/p300 in interferon γ signaling
Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C. M., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15092 · Cited by 483
Neoantigen landscape dynamics during human melanoma–T cell interactions
Verdegaal, E. M. E., de Miranda, N. F. C. C., Visser, M., Harryvan, T., van Buuren, M. M., Andersen, R. S., Hadrup, S. R., van der Minne, C. E., Schotte, R., Spits, H., et al. (2016) · Nature · doi:10.1038/nature18945 · Cited by 461
Greenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06422.x · Cited by 454
Self-citationCloning and expression of murine immune interferon cDNA.
Gray, P. W., & Goeddel, D. V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5842 · Cited by 446
Negishi, H., Taniguchi, T., & Yanai, H. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 445
Interaction of NF-κB and NFAT with the Interferon-γ Promoter
Sica, A., Dorman, L., Viggiano, V., Cippitelli, M., Ghosh, P., Rice, N., & Young, H. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30412 · Cited by 429
Three-dimensional structure of recombinant human interferon-gamma
Ealick, S., Cook, W., Vijay-Kumar, S., Carson, M., Nagabhushan, T., Trotta, P., & Bugg, C. (1991) · Science · doi:10.1126/science.1902591 · Cited by 426
Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T., & Kishimoto, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11349 · Cited by 408
Stevanović, S., Pasetto, A., Helman, S. R., Gartner, J. J., Prickett, T. D., Howie, B., Robins, H. S., Robbins, P. F., Klebanoff, C. A., Rosenberg, S. A., et al. (2017) · Science · doi:10.1126/science.aak9510 · Cited by 383
Agnello, D., Lankford, C. S. R., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., & Frucht, D. M. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1023381027062 · Cited by 378
You, M., Yu, D.-H., & Feng, G.-S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2416 · Cited by 364
Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor
Walter, M. R., Windsor, W. T., Nagabhushan, T. L., Lundell, D. J., Lunn, C. A., Zauodny, P. J., & Narula, S. K. (1995) · Nature · doi:10.1038/376230a0 · Cited by 359
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C. M., Arthur, C., White, J. M., Uppaluri, R., Andrews, D. M., Ngiow, S. F., Teng, M. W. L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112738 · Cited by 348
Self-citationBiologic consequences of Stat1-independent IFN signaling
Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., & Schreiber, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111163898 · Cited by 344
Self-citationA direct role for IFN-γ in regulation of Th1 cell development
Bradley, L. M., Dalton, D. K., & Croft, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1350 · Cited by 319
Gaczynska, M., Rock, K. L., Spies, T., & Goldberg, A. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9213 · Cited by 312
IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide.
Snapper, C. M., Peschel, C., & Paul, W. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2121 · Cited by 307
Greenlund, A. C., Morales, M. O., Viviano, B. L., Yan, H., Krolewski, J., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90012-8 · Cited by 304
Self-citationMüller-Hermelink, N., Braumüller, H., Pichler, B., Wieder, T., Mailhammer, R., Schaak, K., Ghoreschi, K., Yazdi, A., Haubner, R., Sander, C. A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.001 · Cited by 302
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Noguchi, T., Ward, J. P., Gubin, M. M., Arthur, C. D., Lee, S. H., Hundal, J., Selby, M. J., Graziano, R. F., Mardis, E. R., Korman, A. J., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0391 · Cited by 302
Self-citationFatal Melanoma Transferred in a Donated Kidney 16 Years after Melanoma Surgery
MacKie, R. M., Reid, R., & Junor, B. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302063480620 · Cited by 290
Invariant NKT Cells Amplify the Innate Immune Response to Lipopolysaccharide
Nagarajan, N. A., & Kronenberg, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2706 · Cited by 289
Lack of Interferon γ Receptor β Chain and the Prevention of Interferon γ Signaling in T H 1 Cells
Pernis, A., Gupta, S., Gollob, K. J., Garfein, E., Coffman, R. L., Schindler, C., & Rothman, P. (1995) · Science · doi:10.1126/science.7618088 · Cited by 285
Schreiber, R. D., Hicks, L. J., Celada, A., Buchmeier, N. A., & Gray, P. W. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1609 · Cited by 284
Self-citationWolf, P. R., & Ploegh, H. L. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.001411 · Cited by 278
Hoshino, K., Tsutsui, H., Kawai, T., Takeda, K., Nakanishi, K., Takeda, Y., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5041 · Cited by 277
The Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases
Tanner, J. W., Chen, W., Young, R. L., Longmore, G. D., & Shaw, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6523 · Cited by 247
Nguyen, H., Ramana, C. V., Bayes, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105070200 · Cited by 247
Reis, L. F., Harada, H., Wolchok, J. D., Taniguchi, T., & Vilcek, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05041.x · Cited by 243
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.
Maraskovsky, E., Chen, W. F., & Shortman, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1210 · Cited by 238
Igarashi, K., Garotta, G., Ozmen, L., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Larner, A. C., & Finbloom, D. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36621-8 · Cited by 218
Ligand-Induced Autoregulation of IFN-γ Receptor β Chain Expression in T Helper Cell Subsets
Bach, E. A., Szabo, S. J., Dighe, A. S., Ashkenazi, A., Aguet, M., Murphy, K. M., & Schreiber, R. D. (1995) · Science · doi:10.1126/science.270.5239.1215 · Cited by 214
Self-citationOuchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 201
Yang, J., Murphy, T. L., Ouyang, W., & Murphy, K. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<548::aid-immu548>3.0.co;2-z · Cited by 199
Penix, L., Weaver, W. M., Pang, Y., Young, H. A., & Wilson, C. B. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1483 · Cited by 199
Penix, L. A., Sweetser, M. T., Weaver, W. M., Hoeffler, J. P., Kerppola, T. K., & Wilson, C. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31964 · Cited by 195
Trent, J. M., Olson, S., & Lawn, R. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7809 · Cited by 188
Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, Narazaki, M., Adachi, K., Yoshimoto, T., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00132-7 · Cited by 186
Interaction between the Components of the Interferon γ Receptor Complex
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Mariano, T. M., Donnelly, R. J., Muthukumaran, G., Cook, J. R., Garotta, G., Silvennoinen, O., Ihle, J. N., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20915 · Cited by 164
Metabolic Regulation of Natural Killer Cell IFN-γ Production
Mah, A. Y., & Cooper, M. A. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016017387 · Cited by 161
Ligand-Induced Assembly and Activation of the Gamma Interferon Receptor in Intact Cells
Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., & Schreiber, R. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.3214 · Cited by 145
Self-citationMatsuda, J. L., Zhang, Q., Ndonye, R. M., Richardson, S. K., Howell, A. R., & Gapin, L. (2005) · Blood · doi:10.1182/blood-2005-08-3103 · Cited by 145
Interferon-γ is an autocrine mediator for dendritic cell maturation
Pan, J., Zhang, M., Wang, J., Wang, Q., Xia, D., Sun, W., Zhang, L., Yu, H. C., Liu, Y.-J., & Cao, X. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.003 · Cited by 144
Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma.
Jung, V., Rashidbaigi, A., Jones, C., Tischfield, J. A., Shows, T. B., & Pestka, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4151 · Cited by 143
Sakatsume, M., Igarashi, K., Winestock, K. D., Garotta, G., Larner, A. C., & Finbloom, D. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17528 · Cited by 140
Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
Teng, M. W. L., Vesely, M. D., Duret, H., McLaughlin, N. M., Towne, J. E., Schreiber, R. D., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1337 · Cited by 128
Self-citationNacy, C. A., Fortier, A. H., Meltzer, M. S., Buchmeier, N. A., & Schreiber, R. D. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3505 · Cited by 127
Self-citationMandal, M., Bandyopadhyay, D., Goepfert, T. M., & Kumar, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201529 · Cited by 122
Phospholipase C-γ2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors
Tassi, I., Presti, R., Kim, S., Yokoyama, W. M., Gilfillan, S., & Colonna, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.749 · Cited by 121
Chang, C., Hammer, J., Loh, J. E., Fodor, W. L., & Flavell, R. (1992) · Immunogenetics · doi:10.1007/bf00179793 · Cited by 109
NK Cells and Cancer Immunoediting
Guillerey, C., & Smyth, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_446 · Cited by 106
Identification of an Interferon-γ Receptor α Chain Sequence Required for JAK-1 Binding
Kaplan, D. H., Greenlund, A. C., Tanner, J. W., Shaw, A. S., & Schreiber, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.9 · Cited by 105
Self-citationOriss, T. B., McCarthy, S. A., Morel, B. F., Campana, M. A. K., & Morel, P. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3666 · Cited by 103
Farrar, M. A., Campbell, J. D., & Schreiber, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11706 · Cited by 103
Self-citationA Milestone Review on How Macrophages Affect Tumor Growth
Caux, C., Ramos, R. N., Prendergast, G. C., Bendriss‐Vermare, N., & Ménétrier‐Caux, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2631 · Cited by 103
Interferon-gamma induces receptor dimerization in solution and on cells.
Greenlund, A. C., Schreiber, R. D., Goeddel, D. V., & Pennica, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46817-7 · Cited by 101
Self-citationDynamic Regulation of IFN-γ Signaling in Antigen-Specific CD8+ T Cells Responding to Infection
Haring, J. S., Corbin, G. A., & Harty, J. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6791 · Cited by 100
Farrar, M. A., Fernández-Luna, J. L., & Schreiber, R. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55039-0 · Cited by 96
Self-citationMarsters, S. A., Pennica, D., Bach, E. A., Schreiber, R. D., & Ashkenazi, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5401 · Cited by 94
Self-citationInterferon γ Stabilizes the T Helper Cell Type 1 Phenotype
Zhang, Y., Apilado, R.-G., Coleman, J. M., Ben-Sasson, S. Z., Tsang, S., Hu‐Li, J., Paul, W. E., & Huang, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.165 · Cited by 83
Stoichiometry of interaction between interferon γ and its receptor
Fountoulakis, M., Zulauf, M., Lustig, A., & Garotta, G. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17248.x · Cited by 82
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
Zhao, F., Sucker, A., Horn, S., Heeke, C., Bielefeld, N., Schrörs, B., Bicker, A., Lindemann, M., Roesch, A., Gaudernack, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0008 · Cited by 74
The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies
Wallach, D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028431 · Cited by 66
Snapper, C. M., Peçanha, L. M., Levine, A. D., & Mond, J. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1163 · Cited by 66
CCAAT/Enhancer-binding Protein-β Regulates Interferon-induced Transcription through a Novel Element
Roy, S. K., Wachira, S. J., Weihua, X., Hu, J., & Kalvakolanu, D. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12626 · Cited by 66
Arakawa, T., Hsu, Y. R., Parker, C. G., & Lai, P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83943-1 · Cited by 64
Dighe, A. S., Farrar, M. A., & Schreiber, R. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82246-3 · Cited by 50
Self-citationHibino, Y., Mariano, T. M., Kumar, C. S., Kozak, C. A., & Pestka, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89594-5 · Cited by 48
Leinikki, P. O., Calderón, J., Luquette, M. H., & Schreiber, R. D. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3360 · Cited by 46
Self-citationAbed, N. S., Chace, J. H., Fleming, A. L., et al. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1034 · Cited by 46
Biosynthetic analysis of the human interferon-γ receptor
Hershey, G. K. K., & Schreiber, R. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80163-6 · Cited by 44
Self-citationPfizenmaier, K., Wiegmann, K., Scheurich, P., Krönke, M., Merlin, G., Aguet, M., Knowles, B. B., & Üçer, U. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.856 · Cited by 31
Abstract 3987: Merlin is a negative regulator of human melanoma
Murray, L. B., Lau, I., & Yu, Q. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3987 · Cited by 10
Regulation of Mouse NK Cells by Structurally Divergent Inhibitory Receptors
Wang, L. L., & Yokoyama, W. M. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_1 · Cited by 6
Cited by
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00228-x · Cited by 1,234
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Harnessing cytokines and chemokines for cancer therapy
Propper, D. J., & Balkwill, F. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00588-9 · Cited by 989
Cancer immunotherapy: Pros, cons and beyond
Tan, S., Li, D., & Zhu, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109821 · Cited by 688
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Bald, T., Krummel, M. F., Smyth, M. J., & Barry, K. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0728-z · Cited by 506
Metadata
- Authors
- Alspach, E., Lussier, D. M., & Schreiber, R. D.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2018-04-16
- Volume
- 11
- Issue
- 3
- Pages
- a028480
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2799849968
- Cited by
- 603
- References
- 128
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.